Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Chromosome 6 open reading frame 35 pseudogene" (also known as transmembrane protein 242 pseudogene, LOC100506911) is a pseudogene and not a protein-coding gene or functional molecule. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they typically arise from gene duplications or retrotranspositions that acquire disabling mutations and lose protein-coding capability. There is no evidence that this pseudogene encodes a functional receptor, enzyme, transporter, or other druggable protein target. Therefore, it is not considered a therapeutic target, has no known molecular function, does not take part in biological pathways, and has no known disease associations, clinical biomarkers, or safety concerns. Note: TMEM242 (transmembrane protein 242), a distinct but related protein-coding gene also found on chromosome 6 and sometimes referred to as C6orf35, is a mitochondrial membrane protein involved in the assembly of the ATP synthase complex and is not a pseudogene[1][2][8]. The query refers specifically to a pseudogene, not the functional gene product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 35 pseudogene.